Related Experiment Videos
A case of chronic mountain sickness diagnosed by routine pulmonary function tests
M Klepper1, P Barnard, W Eschenbacher
1Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston.
Chest
|September 1, 1991
Summary
Chronic mountain sickness (CMS) in altitude natives can stem from a depressed ventilatory drive, not just primary lung disease. Diagnosis is achievable using standard blood gas and pulmonary function tests.
Area of Science:
- Pulmonary Medicine
- Sleep Medicine
- Altitude Physiology
Background:
- Cor pulmonale and respiratory acidosis can present diagnostic challenges, particularly in differentiating primary cardiopulmonary disease from central ventilatory control abnormalities.
- Altitude natives often exhibit blunted responses to hypoxia and hypercapnia, with a subset showing a significantly reduced drive to breathe.
Observation:
- A patient presented with symptoms suggestive of cardiopulmonary disease, but arterial blood gases revealed a normal alveolar-arterial gradient, indicating hypoxemia due to hypoventilation.
- Pulmonary function tests showed evidence of air trapping but otherwise normal parameters, further complicating the diagnosis.
- The patient exhibited frequent and severe nocturnal desaturations with hypopnea, consistent with abnormal ventilatory control during sleep.
Findings:
- The clinical presentation and diagnostic findings supported a diagnosis of chronic mountain sickness (CMS), also known as Monge's disease.
- The diagnosis was established using routine arterial blood gases and standard pulmonary function tests, without the need for more specialized ventilatory responsiveness testing.
Implications:
- This case highlights that CMS, characterized by a profoundly depressed ventilatory drive, should be considered in altitude natives with unexplained hypoxemia and respiratory abnormalities.
- Standard, non-invasive diagnostic tools are sufficient for identifying CMS, simplifying the diagnostic pathway for clinicians.
- Understanding the central ventilatory drive abnormalities is crucial for managing hypoxemia and related complications in high-altitude populations.